Viewing Study NCT03290950


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2026-01-16 @ 5:33 AM
Study NCT ID: NCT03290950
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2017-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 17-352
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View